Kidney transplant recipient
Clinical trials for Kidney transplant recipient explained in plain language.
Never miss a new study
Get alerted when new Kidney transplant recipient trials appear
Sign up with your email to follow new studies for Kidney transplant recipient, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Aiming for less medication after kidney transplant: a trial tests a safer path for older adults
Disease control Not yet recruitingThis trial tests whether older adults who had a kidney transplant more than a year ago can safely stop taking mycophenolate mofetil (MMF), a drug that helps prevent rejection but can cause infections, stomach issues, and cancer over time. Researchers will use blood and urine test…
Matched conditions: KIDNEY TRANSPLANT RECIPIENT
Early phase 1 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Immunotherapy may treat skin cancer in kidney transplant patients without rejection
Disease control Not yet recruitingThis trial investigates whether the immunotherapy drug cemiplimab can shrink advanced cutaneous squamous cell carcinoma in people who have received a kidney transplant. Because immunotherapy can trigger organ rejection, participants also receive the steroid prednisone to protect …
Matched conditions: KIDNEY TRANSPLANT RECIPIENT
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Washing kidneys to stop hidden virus: new trial aims to make transplants safer
Disease control Not yet recruitingThis early-stage trial tests whether treating a donor kidney with a drug called SYN002 before transplant can safely reduce the risk of passing cytomegalovirus (CMV) to the recipient. About 12 adults waiting for a kidney transplant will receive a treated organ. The main goal is to…
Matched conditions: KIDNEY TRANSPLANT RECIPIENT
Early phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a diabetes drug stop diabetes before it starts in transplant patients?
Prevention Not yet recruitingResearchers are testing whether semaglutide, a drug used for diabetes and weight loss, can prevent post-transplant diabetes in kidney transplant recipients. The trial enrolls 37 adults who are 4 to 12 weeks past transplant and at risk for diabetes. Participants receive weekly sem…
Matched conditions: KIDNEY TRANSPLANT RECIPIENT
Phase 2/3 • Sponsor: University Health Network, Toronto • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Could a common diabetes drug stop diabetes after kidney transplant?
Prevention Not yet recruitingThis trial tests whether taking dapagliflozin (Forxiga) for 12 months can prevent post-transplant diabetes in kidney transplant recipients who do not have diabetes. The study includes 184 adults who recently received a kidney transplant and are on standard immunosuppressive thera…
Matched conditions: KIDNEY TRANSPLANT RECIPIENT
Phase 2 • Sponsor: Odense University Hospital • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC